The 4th Annual MarketsandMarkets Orphan Drugs and Rare Diseases Conference, scheduled for October 9–10 in London, United Kingdom ,aims to provide a valuable and broad platform to discuss recent advances in the development of life-saving therapies, critical issues, and strategies to enhance orphan drug development in near future. The conference will bring together scientists, researchers, entrepreneurs, academicians, medical officials, and technologists across the globe to discuss the newest findings in the areas of rare diseases and orphan drugs, helping to shape present and upcoming challenges in drug analysis. It gives participants the chance to interact with industry peers and participate in this scientific conference while staying informed about the most recent developments in the study of rare diseases.

Highlights

• Current landscape of Orphan Drugs across the globe.
• Latest Developments in Orphan drug regulations in Europe.
• Next Generation therapies treating uncommon/rare infections.
• Practices to enhance access to patient data.
• Clinical development & regulatory.
• Digital health and Artificial intelligence.
• Existing roadblocks in orphan drug development.
• Patient Advocacy groups and their role in market access
• Pricing and marketing plans for orphan medications.
• Revolutionary changes approaching rare diseases.
• Rare Genetic disorders: Novel Treatment Strategies.
• Rare Neurological and oncological disorders.
• Development of multi-omics methods for RD diagnosis.
• Role of Personalized Treatment in rare diseases.
• Regenerative Medicine Approaches to fight Complex RDs.

Read on sciencedz.net

Continue reading at sciencedz.net

Next Generation ACO Model Digital Health Drugs

Facebook Share

Twitter Share

Linkedin Share

Email Share